Your session is about to expire
← Back to Search
Proflavine Hemisulfate for Colon Polyps
Phase < 1
Waitlist Available
Led By Sharmila Anandasabapathy, MD
Research Sponsored by Anandasabapathy, Sharmila, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Study Summary
The overall objective of this study is to obtain data to evaluate whether high-resolution imaging of the colon can assist clinicians in detecting dysplastic (precancerous) and neoplastic areas. This is a pilot study of a novel technology, a miniaturized microscope device which can be used during standard endoscopy to image the gastrointestinal epithelium. Theoretically, by visualizing superficial mucosal changes at a high-resolution and magnification, the investigators will be able to obtain optical images that can be used to guide endoscopic biopsy and polypectomy. This may foster the selective targeting of dysplasia/neoplasia, thereby improving diagnostic accuracy.
Eligible Conditions
- Colon Polyps
- Colonic Dysplasia
- Anal Intraepithelial Neoplasia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
to determine whether tissue in nepoplastic or non-neoplastic
Trial Design
1Treatment groups
Experimental Treatment
Group I: Proflavine HemisulfateExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Proflavine
FDA approved
Find a Location
Who is running the clinical trial?
Anandasabapathy, Sharmila, M.D.Lead Sponsor
7 Previous Clinical Trials
1,648 Total Patients Enrolled
Sharmila Anandasabapathy, MDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
5 Previous Clinical Trials
1,674 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger